Hemobilia Following Percutaneous Liver Biopsy

role of percutaneous liver biopsy

Morbidity after percutaneous liver biopsy.

The safety of percutaneous liver biopsy with a 1.2 mm Menghini needle in infants aged one year or less was investigated. One hundred and eighty four procedures performed from 1975 to 1985 were reviewed. There were no deaths or major complications within 48 hours associated with the procedure. In five instances specific complications occurred: a drop in haemoglobin concentration (three), transie...

Role of Percutaneous Liver Biopsy

We read the interesting study by Szymczak et al. (1) regarding the safety and effectiveness of a blind per-cutaneous liver biopsy, where they concluded that the failure rate and the risk of complications are low if indications and contraindications are carefully considered. Moreover, these authors emphasize how important it is that biopsies are performed by skilled and experienced operators. Th...

Hemoperitoneum after percutaneous liver biopsy

Percutaneous liver biopsy (PLB) is an in or out-patient procedure diffused in most hospitals. A particularely elevate number of biopsies in our area depends on endemic infection by hepatitis B and C viruses. Nowadays it is a very safe procedure, and the actual risk of bleeding is estimated to range between 0.04 and 0.16% in nonmalignant disease 1. Major bleeding generally requires a prompt surg...

Bilateral pneumothorax following percutaneous renal biopsy.

Percutaneous renal biopsy is an important tool for defining the type and severity of many renal diseases. Modifications in the procedure have been made from time to time. The latest innovation has focused on more accurate localization of the kidney by ultrasound localization prior to biopsy. From a large series published in the literature it appears that renal biopsy is almost without risk. How...